Literature DB >> 26068590

Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism.

E Lemarchand1, E Maubert1, B Haelewyn2, C Ali1, M Rubio1, D Vivien1.   

Abstract

In the central nervous system, tissue-type plasminogen activator (tPA) has been associated with both pro-death and prosurvival actions on neurons. In most cases, this has been related to exogenous tPA. In the present study, we addressed the influence of endogenous tPA. We first observed an increased transcription of tPA following either in vivo global brain ischemia in rats or in vitro oxygen glucose deprivation (OGD) on mice and rats hippocampal slices. Hippocampal slices from tPA-deficient mice were more sensitive to OGD than wild-type slices. Pharmacological approaches targeting the known receptors of tPA revealed that only the inhibition of phosphorylation of epidermal growth factor receptors (EGFRs) prevented the neuroprotective effect of endogenous tPA. This study shows that ischemic hippocampal neurons overproduce endogenous tPA as an intend to protect themselves from ischemic death, by a mechanism involving an activation of EGFRs. Thus, strategies contributing to promote either endogenous production of tPA or its associated EGFR-linked signaling pathway may have beneficial effects following brain injuries such as stroke.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26068590      PMCID: PMC4815983          DOI: 10.1038/cdd.2015.76

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  47 in total

1.  A simple method for organotypic cultures of nervous tissue.

Authors:  L Stoppini; P A Buchs; D Muller
Journal:  J Neurosci Methods       Date:  1991-04       Impact factor: 2.390

2.  Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity.

Authors:  Géraldine Liot; Benoit D Roussel; Nathalie Lebeurrier; Karim Benchenane; José P López-Atalaya; Denis Vivien; Carine Ali
Journal:  J Neurochem       Date:  2006-06-27       Impact factor: 5.372

3.  A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators.

Authors:  E Angles-Cano
Journal:  Anal Biochem       Date:  1986-03       Impact factor: 3.365

4.  Solid-phase fibrin-tissue-plasminogen-activator activity assay (SOFIA-tPA): tPA but not UK is specifically detected.

Authors:  B Boutière; D Arnoux; P Benchimol; J Sampol; P Risède; E Anglés-Cano
Journal:  Thromb Res       Date:  1986-07-01       Impact factor: 3.944

5.  Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.

Authors:  Karim Benchenane; Hervé Castel; Michel Boulouard; Rosemarie Bluthé; Monica Fernandez-Monreal; Benoit D Roussel; José P Lopez-Atalaya; Sabrina Butt-Gueulle; Véronique Agin; Eric Maubert; Robert Dantzer; Omar Touzani; François Dauphin; Denis Vivien; Carine Ali
Journal:  J Cell Sci       Date:  2007-01-23       Impact factor: 5.285

6.  Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons.

Authors:  Hee-Young Lee; Ih-Yeon Hwang; Hana Im; Jae-Young Koh; Yang-Hee Kim
Journal:  J Neurochem       Date:  2007-06       Impact factor: 5.372

7.  Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note.

Authors:  Isin Unal-Cevik; Münire Kilinç; Yasemin Gürsoy-Ozdemir; Gunfer Gurer; Turgay Dalkara
Journal:  Brain Res       Date:  2004-07-23       Impact factor: 3.252

8.  Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.

Authors:  V Fleury; S Loyau; H R Lijnen; W Nieuwenhuizen; E Anglés-Cano
Journal:  Eur J Biochem       Date:  1993-09-01

9.  Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation.

Authors:  Z Qian; M E Gilbert; M A Colicos; E R Kandel; D Kuhl
Journal:  Nature       Date:  1993-02-04       Impact factor: 49.962

10.  Tissue plasminogen activator prevents white matter damage following stroke.

Authors:  Fernando Correa; Maxime Gauberti; Jérôme Parcq; Richard Macrez; Yannick Hommet; Pauline Obiang; Miriam Hernangómez; Axel Montagne; Géraldine Liot; Carmen Guaza; Eric Maubert; Carine Ali; Denis Vivien; Fabian Docagne
Journal:  J Exp Med       Date:  2011-05-16       Impact factor: 14.307

View more
  11 in total

1.  Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.

Authors:  Shan Liu; Xiaozhou Feng; Rong Jin; Guohong Li
Journal:  Expert Opin Drug Deliv       Date:  2017-09-28       Impact factor: 6.648

2.  Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death.

Authors:  Morgane Louessard; Isabelle Bardou; Eloïse Lemarchand; Audrey M Thiebaut; Jérôme Parcq; Jérôme Leprince; Anne Terrisse; Valérie Carraro; Pierre Fafournoux; Alain Bruhat; Cyrille Orset; Denis Vivien; Carine Ali; Benoit D Roussel
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

3.  Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia.

Authors:  Audrey M Thiebaut; Izaskun Buendia; Vanessa Ginet; Eloise Lemarchand; Mehdi Boutagouga Boudjadja; Yannick Hommet; Laurent Lebouvier; Charlotte Lechevallier; Mike Maillasson; Elodie Hedou; Nicole Déglon; Franck Oury; Marina Rubio; Joan Montaner; Julien Puyal; Denis Vivien; Benoit D Roussel
Journal:  Autophagy       Date:  2021-09-14       Impact factor: 13.391

4.  In Vitro Evaluation of the Neuroprotective Effect of Panax notoginseng Saponins by Activating the EGFR/PI3K/AKT Pathway.

Authors:  Shuang Wu; Tiantian Yang; Kai Cen; Yihuai Zou; Xiaowei Shi; Dongrui Zhou; Yonghong Gao; Limin Chai; Yizhou Zhao; Yikun Sun; Lingqun Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-31       Impact factor: 2.629

5.  Assessment of recombinant tissue plasminogen activator (rtPA) toxicity in cultured neural cells and subsequent treatment with poly-arginine peptide R18D.

Authors:  Jade E Kenna; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Neurochem Res       Date:  2020-03-05       Impact factor: 3.996

6.  Tissue plasminogen activator promotes white matter integrity and functional recovery in a murine model of traumatic brain injury.

Authors:  Yuguo Xia; Hongjian Pu; Rehana K Leak; Yejie Shi; Hongfeng Mu; Xiaoming Hu; Zhengyu Lu; Lesley M Foley; T Kevin Hitchens; C Edward Dixon; Michael V L Bennett; Jun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-10       Impact factor: 11.205

Review 7.  Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis.

Authors:  Mei-Xue Dong; Qing-Chuan Hu; Peng Shen; Jun-Xi Pan; You-Dong Wei; Yi-Yun Liu; Yi-Fei Ren; Zi-Hong Liang; Hai-Yang Wang; Li-Bo Zhao; Peng Xie
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240

8.  Networks of blood proteins in the neuroimmunology of schizophrenia.

Authors:  Clark D Jeffries; Diana O Perkins; Margot Fournier; Kim Q Do; Michel Cuenod; Ines Khadimallah; Enrico Domenici; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods
Journal:  Transl Psychiatry       Date:  2018-06-06       Impact factor: 6.222

Review 9.  Regulatory T cells in ischemic stroke.

Authors:  Huan Wang; Zhao Wang; Qianqian Wu; Yujia Yuan; Wen Cao; Xiangjian Zhang
Journal:  CNS Neurosci Ther       Date:  2021-01-20       Impact factor: 5.243

Review 10.  Impacts of tissue-type plasminogen activator (tPA) on neuronal survival.

Authors:  Arnaud Chevilley; Flavie Lesept; Sophie Lenoir; Carine Ali; Jérôme Parcq; Denis Vivien
Journal:  Front Cell Neurosci       Date:  2015-10-16       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.